Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria

NCT06819774 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

284

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Urticaria

Interventions

DRUG: Cetirizine Hydrochloride Injection
DRUG: Diphenhydramine Hydrochloride Injection

Sponsor

Shandong New Time Pharmaceutical Co., LTD